(Q28359815)

English

Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice (English)

0 references

1 reference

W D Cooper

1

0 references

D Sheldon

series ordinal

2

0 references

D Brown

series ordinal

3

0 references

G R Kimber

series ordinal

4

0 references

V L Isitt

series ordinal

5

0 references

W J Currie

series ordinal

6

0 references

language of work or name

English

0 references

publication date

August 1987

0 references

published in

The Journal of the Royal College of General Practitioners

0 references

volume

37

0 references

page(s)

346-9

0 references

issue

301

0 references

cites work

Postmarketing surveillance of adverse reactions to drugs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1711010

retrieved

29 September 2017

Review of the Overall Experience of Captopril in Hypertension

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1711010

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1711010

retrieved

29 September 2017

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1711010

retrieved

29 September 2017

Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1711010

retrieved

2 June 2018

Captopril-induced angioedema

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2834550

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2834550

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enalapril Worldwide Experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2834550

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cough and wheeze caused by inhibitors of angiotensin-converting enzyme

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2834550

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enalapril-induced cough

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2834550

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

(Q28359815)

Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)